• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际放射肿瘤学进展会议(ICARO):IAEA 会议的结果。

International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting.

机构信息

STUK, Finnish Radiation and Nuclear Safety Authority and Department of Radiation Oncology Turku University Hospital, Finland.

出版信息

Radiat Oncol. 2011 Feb 4;6:11. doi: 10.1186/1748-717X-6-11.

DOI:10.1186/1748-717X-6-11
PMID:21294881
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3042948/
Abstract

The IAEA held the International Conference on Advances in Radiation Oncology (ICARO) in Vienna on 27-29 April 2009. The Conference dealt with the issues and requirements posed by the transition from conventional radiotherapy to advanced modern technologies, including staffing, training, treatment planning and delivery, quality assurance (QA) and the optimal use of available resources. The current role of advanced technologies (defined as 3-dimensional and/or image guided treatment with photons or particles) in current clinical practice and future scenarios were discussed.ICARO was organized by the IAEA at the request of the Member States and co-sponsored and supported by other international organizations to assess advances in technologies in radiation oncology in the face of economic challenges that most countries confront. Participants submitted research contributions, which were reviewed by a scientific committee and presented via 46 lectures and 103 posters. There were 327 participants from 70 Member States as well as participants from industry and government. The ICARO meeting provided an independent forum for the interaction of participants from developed and developing countries on current and developing issues related to radiation oncology.

摘要

国际原子能机构于 2009 年 4 月 27 日至 29 日在维也纳举行了国际放射肿瘤学进展会议(ICARO)。会议讨论了从传统放射治疗向先进现代技术过渡所带来的问题和需求,包括人员配备、培训、治疗计划和实施、质量保证(QA)以及充分利用现有资源等问题。会议还讨论了先进技术(定义为使用光子或粒子的三维和/或图像引导治疗)在当前临床实践和未来应用场景中的作用。

应成员国的要求,国际原子能机构组织了此次会议,其他国际组织也共同赞助和支持了此次会议,以评估放射肿瘤学领域技术的最新进展,应对大多数国家面临的经济挑战。会议参与者提交了研究报告,这些报告由科学委员会进行了评审,并通过 46 次演讲和 103 份海报进行了介绍。来自 70 个成员国的 327 名参与者以及来自工业界和政府的代表参加了会议。ICARO 会议为发达国家和发展中国家的参与者就与放射肿瘤学相关的当前和正在出现的问题进行互动提供了一个独立的论坛。

相似文献

1
International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting.国际放射肿瘤学进展会议(ICARO):IAEA 会议的结果。
Radiat Oncol. 2011 Feb 4;6:11. doi: 10.1186/1748-717X-6-11.
2
Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".现代基于图像的放射治疗的质量保证需求:来自2007年“放射治疗质量保证:先进技术挑战”跨组织研讨会的建议
Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S2-12. doi: 10.1016/j.ijrobp.2007.08.080.
3
IAEA support to medical physics in nuclear medicine.IAEA 在核医学中的医学物理支持。
Semin Nucl Med. 2013 May;43(3):181-7. doi: 10.1053/j.semnuclmed.2012.11.008.
4
Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives.通过国际原子能机构全球近距离放射治疗计划解决宫颈癌负担。
Brachytherapy. 2020 Nov-Dec;19(6):850-856. doi: 10.1016/j.brachy.2020.07.015. Epub 2020 Sep 11.
5
Safety in radiation oncology: the role of international initiatives by the International Atomic Energy Agency.放射肿瘤学中的安全性:国际原子能机构国际倡议的作用。
J Am Coll Radiol. 2011 Nov;8(11):789-94. doi: 10.1016/j.jacr.2011.07.014.
6
The Ever-Evolving Role of the Academic Clinical Physicist.学术临床物理学家不断演变的角色。
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):18-20. doi: 10.1016/j.ijrobp.2017.01.241.
7
International perspectives on quality assurance and new techniques in radiation medicine: outcomes of an IAEA conference.国际辐射医学质量保证与新技术视角:国际原子能机构会议成果
Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S80-4. doi: 10.1016/j.ijrobp.2007.07.2390.
8
Education and Training Needs in Radiation Oncology in India: Opportunities for Indo-US Collaborations.印度放射肿瘤学的教育和培训需求:印美合作的机会。
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):957-60. doi: 10.1016/j.ijrobp.2015.08.009. Epub 2015 Aug 7.
9
Quality assurance in radiation oncology.放射肿瘤学中的质量保证
J Am Coll Radiol. 2005 Jul;2(7):613-6. doi: 10.1016/j.jacr.2005.02.004.
10
BIGART 2019 - adapting to the future.2019年大艺术展——适应未来。
Acta Oncol. 2019 Oct;58(10):1323-1327. doi: 10.1080/0284186X.2019.1657587.

引用本文的文献

1
Effects of Radiotherapy Upon Bone Structure-Strength Relationships Vary With Sex and Fractionation of Dosing.放疗对骨结构-强度关系的影响因性别和剂量分割方式而异。
Iowa Orthop J. 2023;43(1):77-86.
2
Comparative Analysis of 60Co and 192Ir Sources in High Dose Rate Brachytherapy for Cervical Cancer.60钴和192铱源在宫颈癌高剂量率近距离治疗中的对比分析
Cancers (Basel). 2022 Sep 29;14(19):4749. doi: 10.3390/cancers14194749.
3
Assessment of Breast Cancer Management in Sub-Saharan Africa.撒哈拉以南非洲地区乳腺癌管理评估。
JCO Glob Oncol. 2021 Sep;7:1593-1601. doi: 10.1200/GO.21.00282.
4
Cancer in Africa: the way forward.非洲的癌症:前进之路。
Ecancermedicalscience. 2019 Jul 25;13:953. doi: 10.3332/ecancer.2019.953. eCollection 2019.
5
Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources.高剂量率腔内近距离放疗治疗宫颈癌的疗效观察:铱-192 与钴-60 源的比较。
J Gynecol Oncol. 2018 Sep;29(5):e86. doi: 10.3802/jgo.2018.29.e86.
6
Model for Estimating Power and Downtime Effects on Teletherapy Units in Low-Resource Settings.低资源环境下估算远程治疗设备功率和停机时间影响的模型
J Glob Oncol. 2017 Jan 11;3(5):563-571. doi: 10.1200/JGO.2016.005306. eCollection 2017 Oct.
7
IBPRO - A Novel Short-Duration Teaching Course in Advanced Physics and Biology Underlying Cancer Radiotherapy.IBPRO——一门关于癌症放射治疗基础的高级物理与生物学的新型短期教学课程。
Radiat Res. 2017 Jun;187(6):637-640. doi: 10.1667/RR14723.1. Epub 2017 Mar 22.
8
Study of the dosimetric differences between (192)Ir and (60)Co sources of high dose rate brachytherapy for breast interstitial implant.乳腺组织间插植高剂量率近距离治疗中(192)铱源与(60)钴源剂量学差异的研究
Rep Pract Oncol Radiother. 2016 Sep-Oct;21(5):453-9. doi: 10.1016/j.rpor.2016.03.005. Epub 2016 May 11.
9
The future of Radiation Oncology: Considerations of Young Medical Doctor.放射肿瘤学的未来:年轻医生的思考
Rep Pract Oncol Radiother. 2012 Oct 4;17(5):288-93. doi: 10.1016/j.rpor.2012.09.002. eCollection 2012 Sep.
10
Treatment planning study of the 3D dosimetric differences between Co-60 and Ir-192 sources in high dose rate (HDR) brachytherapy for cervix cancer.宫颈癌高剂量率(HDR)近距离治疗中钴-60与铱-192源三维剂量差异的治疗计划研究。
J Contemp Brachytherapy. 2012 Mar;4(1):52-9. doi: 10.5114/jcb.2012.27952. Epub 2012 Mar 30.

本文引用的文献

1
American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer.美国放射肿瘤学会(ASTRO)和美国放射学院(ACR)前列腺癌经会阴永久性近距离放射治疗实践指南。
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):335-41. doi: 10.1016/j.ijrobp.2010.08.045. Epub 2010 Nov 23.
2
High Dose Rate Brachytherapy in the Treatment of cervical cancer: preliminary experience with cobalt 60 Radionuclide source-A Prospective Study.高剂量率近距离放射治疗宫颈癌:钴 60 放射性核素源的初步经验——一项前瞻性研究。
Clin Med Insights Oncol. 2010 Aug 19;4:89-94. doi: 10.4137/cmo.s5269.
3
A survey of image-guided radiation therapy use in the United States.美国的图像引导放射治疗使用情况调查。
Cancer. 2010 Aug 15;116(16):3953-60. doi: 10.1002/cncr.25129.
4
Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.常规剂量联合质子和光子放疗与高剂量联合质子和光子放疗治疗早期前列腺癌患者的长期报告结局。
JAMA. 2010 Mar 17;303(11):1046-53. doi: 10.1001/jama.2010.287.
5
Has the time come for doing away with Cobalt-60 teletherapy for cancer treatments.淘汰用于癌症治疗的钴 - 60远距离放射疗法的时机到了吗?
J Med Phys. 2009 Apr;34(2):63-5. doi: 10.4103/0971-6203.51931.
6
Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society.妇科近距离放射治疗中的三维成像:美国近距离放射治疗学会的调查。
Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):104-9. doi: 10.1016/j.ijrobp.2009.01.043.
7
Current status and future potential of advanced technologies in radiation oncology. Part 2. State of the science by anatomic site.放射肿瘤学中先进技术的现状与未来潜力。第2部分。按解剖部位划分的科学现状。
Oncology (Williston Park). 2009 Apr 15;23(4):380-5.
8
Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources.放射肿瘤学中先进技术的现状与未来潜力。第1部分。挑战与资源。
Oncology (Williston Park). 2009 Mar;23(3):279-83.
9
On the use of HDR 60Co source with the MammoSite radiation therapy system.关于在MammoSite放射治疗系统中使用高剂量率60钴源。
Med Phys. 2008 Dec;35(12):5263-8. doi: 10.1118/1.3002312.
10
The implementation of ablative hypofractionated radiotherapy for stereotactic treatments in the brain and body: observations on efficacy and toxicity in clinical practice.脑部和身体立体定向治疗中消融性大分割放疗的实施:临床实践中的疗效和毒性观察
Semin Radiat Oncol. 2008 Oct;18(4):265-72. doi: 10.1016/j.semradonc.2008.04.009.